Sunday, December 21, 2014   

GSK to sell oncology arm to Novartis
(04-22 14:22)

British pharmaceutical giant GlaxoSmithKline is to sell its oncology business to peer Novartis for US$16 billion and to buy the Swiss company's vaccines division, GSK announced on Tuesday.
Under a "major three-part transaction'' GSK and Novartis have agreed also to create a consumer healthcare business, according to a statement issued by GlaxoSmithKline. --AFP
   
Other Business breaking news:
Govt looks to provide 20k flats this year (12-19 17:21)
German consumer confidence on the rise (12-19 16:58)
BYD recovers partially after plunge (12-19 16:29)
Hang Seng finishes higher (12-19 16:28)
BOC Aviation adds two more Boeing jets to earlier order spree (12-19 14:46)
Nikkei finishes higher (12-19 14:24)
Hang Seng jumps at noon (12-19 13:02)
BoJ strikes more upbeat view on economy, holds off fresh measures (12-19 12:16)
China total GDP revised up 3.4% in 2013: govt (12-19 11:26)
Nikkei up by break (12-19 11:17)

More breaking news >>

© 2014 The Standard, The Standard Newspapers Publishing Ltd.
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts

 


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Spree | Features

The Standard

Trademark and Copyright Notice: Copyright 2014, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use, Privacy Policy Statement and Copyright Policy.  Please also read our Ethics Statement.